Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aclarion Equity Warrant Exp 1st Dec 2026 Warrant

0.0276
-0.0078-22.03%
Volume:29.21K
Turnover:833.34
Market Cap:- -
PE:- -
High:0.0344
Open:0.0344
Low:0.0276
Close:0.0354
Loading ...

Company Profile

Company Name:
Aclarion Equity Warrant Exp 1st Dec 2026 Warrant
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Website:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.